Richard Lowenthal, president and CEO of ARS Pharmaceuticals, shed light on the importance of testing intranasal epinephrine spray ARS-1 (also known as neffy) under extreme temperatures. The concerns raised by parents about leaving the EpiPen in the car and throwing it away due to fears of it getting hot highlighted the need for such testing.
0 Comments
Saudi Arabia’s state oil giant Aramco recently reported a 25% decline in profit for the year 2023, with net income dropping to $121.3 billion from $161.1 billion in the previous year. Despite this decrease, it is noteworthy that this figure still represents the second-highest net income on record for Aramco, surpassing many of its largest
0 Comments
Artificial intelligence has been a game-changer for many technology companies, but the benefits of AI extend beyond the tech sector. According to Nancy Tengler, chief executive officer and chief investment officer of Laffer Tengler Investments, old economy companies that are embracing digital and generative AI are set to experience significant growth and improved profit margins.
0 Comments
The financial success of UnitedHealth Group (UHG) is staggering, with revenue reaching nearly $400 billion in 2023. This massive empire, fueled by profits of $22.4 billion, has raised concerns about the implications of its dominance in the healthcare industry. Through vertical integration and acquisitions like Optum, UHG has established a value-chain monopoly, controlling everything from
0 Comments